Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;27(8):2009-2016.
doi: 10.3201/eid2708.203870. Epub 2021 Jun 17.

Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa

Review

Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa

Victor Williams et al. Emerg Infect Dis. 2021 Aug.

Abstract

The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achieve worldwide immunity. Ensuring COVID-19 vaccination is crucial to stemming the pandemic, reclaiming everyday life, and helping restore economies. However, challenges exist to deploying these vaccines, especially in resource-limited sub-Saharan Africa. In this article, we highlight lessons learned from previous efforts to scale up vaccine distribution and offer considerations for policymakers and key stakeholders to use for successful COVID-19 vaccination rollout in Africa. These considerations range from improving weak infrastructure for managing data and identifying adverse events after immunization to considering financing options for overcoming the logistical challenges of vaccination campaigns and generating demand for vaccine uptake. In addition, providing COVID-19 vaccination can be used to promote the adoption of universal healthcare, especially in sub-Saharan Africa countries.

Keywords: Africa; COVID-19; COVID-19 vaccines; SARS-CoV-2; coronavirus disease; disease control strategies; disease transmission; pandemics; public health logistics; respiratory infections; severe acute respiratory syndrome coronavirus 2; sub-Saharan Africa; vaccination coverage; vaccination programs; vaccinations; viruses; zoonoses.

PubMed Disclaimer

References

    1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard [cited 2021 May 9]. https://covid19.who.int
    1. Altmann DM, Douek DC, Boyton RJ. What policy makers need to know about COVID-19 protective immunity. Lancet. 2020;395:1527–9. 10.1016/S0140-6736(20)30985-5 - DOI - PMC - PubMed
    1. Horton R. Offline: COVID-19-a reckoning. Lancet. 2020;395:935. 10.1016/S0140-6736(20)30669-3 - DOI - PMC - PubMed
    1. Kirkcaldy RD, King BA, Brooks JT. COVID-19 and postinfection immunity: limited evidence, many remaining questions. JAMA. 2020;323:2245–6. 10.1001/jama.2020.7869 - DOI - PMC - PubMed
    1. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020;52:737–41. 10.1016/j.immuni.2020.04.012 - DOI - PMC - PubMed

Substances